Anthrax evildoers revealed

New work has identified the cellular receptor for anthrax toxin and resolved the crystal structure of a component of the toxin.

Written byTudor Toma
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Anthrax toxin, which due to unfortunate circumstances has become a topic of great public interest at the moment, has three parts: lethal factor (LF), oedema factor (OF) and the protective agent (PA). Two papers published in 8 November Nature provide more details about the anthrax toxin components PA and LF, pointing the way to better vaccines and treatments.

In the first paper, Kenneth Bradley and colleagues from University of Wisconsin-Madison, describe the cloning of a cellular receptor for the PA component of the anthrax toxin. The receptor, called ATR (anthrax toxin receptor) is a type I membrane protein with an extracellular von Willebrand factor A domain that binds directly to the protective antigen (PA) of the anthrax toxin.

In the second paper, Andrew Pannifer and colleagues from The Burnham Institute, La Jolla, California, report the crystal structure of another part of the toxin, the anthrax lethal factor (LF). The structure ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Accelerating Recombinase Reprogramming with Machine Learning

Accelerating Recombinase Reprogramming with Machine Learning

Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo

Products

waters-logo

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing

zymo-research-logo

Zymo Research Partners with Harvard University to Bring the BioFestival to Cambridge, Empowering World-class Research

10x-genomics-logo

10x Genomics and A*STAR Genome Institute of Singapore Launch TISHUMAP Study to Advance AI-Driven Drug Target Discovery

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA